Colgate-Palmolive Company (CL) Stake Held by Mar Vista Investment Partners LLC

Paterniano Del Favero
Agosto 3, 2017

Pacer Advisors Inc. increased its stake in Colgate-Palmolive Company (NYSE:CL) by 6.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. "We continue to focus on our priorities of strengthening the core of our business and driving competitive and profitable growth while staying committed to our values and sustainability initiatives", Issam Bachaalani, MD, Colgate-Palmolive (India) said in a statement.

Institutional investors have recently made changes to their positions in the company.

Mumbai: Colgate-Palmolive India Ltd on Thursday reported its market share in toothpastes fell to 54.3%, a sequential decline of 1.3%, even as its net sales declined by 3% year-on-year (y-o-y) for the quarter ended June 2017, while net profit rose 8.4% year-on-year. North Star Investment Management Corp. boosted its position in shares of Colgate-Palmolive by 3.9% in the first quarter. Blue Chip Partners Inc. raised its stake in Colgate-Palmolive by 0.4% in the first quarter. Kistler Tiffany Companies LLC now owns 2,035 shares of the company's stock valued at $149,000 after buying an additional 165 shares during the last quarter. Finally, Heritage Trust Co acquired a new stake in shares of Colgate-Palmolive during the first quarter valued at about $146,000.

Colgate-Palmolive (NYSE CL) traded down 0.11% on Wednesday, reaching $71.62. The stock has a market cap of $63.09 billion, a P/E ratio of 26.61 and a beta of 0.80. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $77.27. The company has a 50 day moving average of $73.87 and a 200 day moving average of $72.62.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 21st. The business had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%.

Meanwhile, the revenue fell 2.7 percent at Rs 1,118 core against Rs 1,149 crore posted during the June quarter a year ago.

Fast moving consumer goods (FMCG) major, Colgate, on Thursday reported 8.5 percent rise in its June quarter net profit at Rs 136.4 crore against Rs 125.7 crore posted during the same period a year ago. Analysts forecast that Colgate-Palmolive Company will post $2.90 EPS for the current year. Shareholders of record on Tuesday, July 18th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, July 14th.

However, the company's total income from operations for the April-June quarter stood at Rs 1,131.01 crore - down 2.43 per cent - from Rs 1,159.17 crore reported during the corresponding period of last fiscal. Colgate-Palmolive's payout ratio is 59.48%. If you are reading this piece on another website, it was stolen and reposted in violation of United States & worldwide trademark and copyright law. The legal version of this piece can be accessed at Jefferies Group LLC lowered their target price on shares of Colgate-Palmolive from $78.00 to $76.00 and set a "hold" rating on the stock in a research note on Monday, May 1st. Bank of America Corporation lifted their price objective on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the company a "buy" rating in a research note on Wednesday, May 31st. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the company's stock. Vetr cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and set a $76.67 price objective for the a research note on Wednesday, May 17th. Also, COO Justin Skala sold 74,374 shares of the business's stock in a transaction that occurred on Thursday, July 27th. Following the completion of the sale, the insider now directly owns 53,022 shares in the company, valued at approximately $4,012,174.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director John T. Cahill sold 8,000 shares of the business's stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $71.53, for a total transaction of $1,001,420.00. Following the completion of the sale, the senior vice president now owns 102,838 shares of the company's stock, valued at $7,356,002.14. The disclosure for this sale can be found here. Blue Chip Partners Inc. now owns 1,805 shares of the company's stock valued at $132,000 after buying an additional 8 shares during the last quarter.

The oral care leader has been facing intense competition from Baba Ramdev-led Patanjali Ayurved's flagship product, herbal toothpaste Dant Kanti.

Altre relazioni OverNewsmagazine

Discuti questo articolo